This is a working overview of metabolite, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport; not approved as medicine | Listed by WADA at all times. |
| Common synonyms | GW501516, GW-501516, endurobol | Cardarine is a colloquial name. |
| Typical analytical method | LC-MS/MS | Detects parent compound and metabolites. |
| Common test matrix | Urine | Blood and dried blood spots also possible. |
| Legal classification | Varies by country | Often treated as unapproved drug or research chemical. |
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Vaccination against mumps did not become routine until Mumpsvax was included in Merck's combined MMR vaccine, which targeted measles and rubella along with mumps. MMR was licensed in 1971, and 40 percent of American children had received the combined vaccine by 1974. In 1977, the U.S. Centers for Disease Control and Prevention (CDC) recommended mumps immunization (as part of MMR) for all children over 12 months of age, and in 1998, CDC began recommending a two-dose immunization of MMR.
== Adaptations == In 2000, Yahoo! reported that MGM and actor/director Tom Hanks were in discussions regarding adapting both 2061: Odyssey Three and 3001: The Final Odyssey into movies, with Hanks reportedly to play Frank Poole in the 3001 film. An update in 2001 stated that there was no further development on the project. On 3 November 2014, it was reported that the US TV channel Syfy had ordered a miniseries adaptation of 3001: The Final Odyssey into production, planned for broadcast in 2015. The miniseries would be executive-produced by Ridley Scott, David W. Zucker and Stuart Beattie; the latter would also be the primary script-writer. The estates of both Clarke and 2001: A Space Odyssey director Stanley Kubrick were reported as having "offered their full support", but the extent of their involvement was not known at the time. In February 2016, within Syfy's press release for its television pilot Prototype, other series including the Final Odyssey series were mentioned as being in development. However, to date, no further progress has been made. The plot of Futurama has similarities, with the character of Fry being frozen for 1000 years (albeit in 1999) and waking in the year 3000.
=== DNA synthesis usage === The term formula weight has a specific meaning when used in the context of DNA synthesis: whereas an individual phosphoramidite nucleobase to be added to a DNA polymer has protecting groups and has its molecular weight quoted including these groups, the amount of molecular weight that is ultimately added by this nucleobase to a DNA polymer is referred to as the nucleobase's formula weight (i.e., the molecular weight of this nucleobase within the DNA polymer, minus protecting groups).
== Early life and education == Cameron was born in Champaign, Illinois. The oldest of three brothers, he grew up in the Chicago suburb, Westchester, and graduated in 1975 from Proviso West High School, Hillside, Illinois. Cameron graduated from Duke University (1979) with a B.S.E. in Biomedical Engineering. In May 1979 he joined Advanced Harvesting Systems, a start-up company focused on large-scale plant protein purification, as the first non-founding member of the company. He was married in August 1979 to Sally Jo Clark. Cameron started graduate school at the Massachusetts Institute of Technology in July 1981 and graduated with a Ph.D. in biochemical engineering in December 1986. His Ph.D. advisor was Charles L. Cooney. His Ph.D. thesis was titled “The Production of R-1,2-Propanediol by Clostridium thermosaccharolyticum.”
Sources: en.wikipedia.org
In biochemistry, the Corey–Pauling rules are a set of three basic statements that govern the secondary nature of proteins, in particular, the CO-NH peptide link. They were originally proposed by Robert Corey and Linus Pauling. The rules are as follows:
== Comparison with HDMI == Although DisplayPort has much of the same functionality as HDMI, it is a complementary connection used in different scenarios. A dual-mode DisplayPort port can emit an HDMI signal via a passive adapter.
A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression, in which case it is a recombinant subunit vaccine. A "subunit" vaccine doesn't contain the whole pathogen, unlike live attenuated or inactivated vaccine, but contains only the antigenic parts such as proteins, polysaccharides or peptides. Because the vaccine doesn't contain "live" components of the pathogen, there is no risk of introducing the disease, and is safer and more stable than vaccines containing whole pathogens. Other advantages include being well-established technology and being suitable for immunocompromised individuals. Disadvantages include being relatively complex to manufacture compared to some vaccines, possibly requiring adjuvants and booster shots, and requiring time to examine which antigenic combinations may work best. The first recombinant subunit vaccine was produced in the mid-1980s to protect people from Hepatitis B. Other recombinant subunit vaccines licensed include Engerix-B (hepatitis B), Gardasil 9 (Human Papillomavirus), Flublok (influenza), Shingrix (Herpes zoster) and Nuvaxovid (Coronavirus disease 2019). After injection, antigens trigger the production of antigen-specific antibodies, which are responsible for recognising and neutralising foreign substances. Basic components of recombinant subunit vaccines include recombinant subunits, adjuvants and carriers.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management. In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
=== Obesity and other hyperalimentation === 278 Obesity and other hyperalimentation 278.0 Obesity, NOS 278.1 Localized adiposity 278.2 Hypervitaminosis A 278.3 Hypercarotenemia 278.4 Hypervitaminosis D
Sources: en.wikipedia.org
==== Electrostatic interactions ==== The glycosaminoglycan in the bioadhesive is hydrophilic in nature due to the presence sulfate, carboxyl and hydroxyl groups. When it is applied to wet surfaces such as bodily tissues, it absorbs interface water which allows for the formation of hydrogen bonds which creates tissue adhesion. Without this, water at the interface would block the hydrogen bond receptors.
According to Grünwedel, "the circles (mandalâni) undoubtedly refer to the edges made of foliage and human skulls", that is the Classical border of acanthus leaves and Buddhist skulls painted along the inferior border of the mural. The word Rumakama, or Romakam appears in the Kizil paintings as well as in the later Tibetan document, and is thought to refer to a painter who came from the Roman Empire or the Byzantine Empire.
White blood cells (scientific name leukocytes), also called immune cells or immunocytes, are cells of the immune system that are involved in protecting the body against both infectious disease and foreign entities. White blood cells are generally larger than red blood cells. They include three main subtypes: granulocytes, lymphocytes and monocytes. All white blood cells are produced and derived from multipotent cells in the bone marrow known as hematopoietic stem cells. Leukocytes are found throughout the body, including the blood and lymphatic system. All white blood cells have nuclei, which distinguishes them from the other blood cells, the anucleated red blood cells (RBCs) and platelets. The different white blood cells are usually classified by cell lineage (myeloid cells or lymphoid cells). White blood cells are part of the body's immune system. They help the body fight infection and other diseases. Types of white blood cells are granulocytes (neutrophils, eosinophils, and basophils), and agranulocytes (monocytes, and lymphocytes (T cells and B cells)). Myeloid cells (myelocytes) include neutrophils, eosinophils, mast cells, basophils, and monocytes. Monocytes are further subdivided into dendritic cells and macrophages. Monocytes, macrophages, and neutrophils are phagocytic. Lymphoid cells (lymphocytes) include T cells (subdivided into helper T cells, memory T cells, cytotoxic T cells), B cells (subdivided into plasma cells and memory B cells), and natural killer cells.
Prior to the Air Pollution Control Act of 1955, little headway was made to initiate this air pollution reform. U.S. cities Chicago and Cincinnati first established smoke ordinances in 1881. In 1904, Philadelphia passed an ordinance limiting the amount of smoke in flues, chimneys, and open spaces. The ordinance imposed a penalty if not all smoke inspections were passed. It was not until 1947 that California authorized the creation of Air Pollution Control Districts in every county of the state.
=== Tracing food sources and diets === Different photosynthetic pathways preferentially select for the lighter 12C, but their selectivity differs. Grasses in temperate climates (barley, rice, wheat, rye, and oats, plus sunflower, potato, tomatoes, peanuts, cotton, sugar beet, and most trees and their nuts or fruits, roses, and Kentucky bluegrass) follow a C3 photosynthetic pathway that will yield δ13C values averaging about −26.5‰. Grasses in hot arid climates (maize in particular, but also millet, sorghum, sugar cane, and crabgrass) follow a C4 photosynthetic pathway that produces δ13C values averaging about −12.5‰. It follows that eating these different plants will affect the δ13C values in the consumer's body tissues. If an animal (or human) eats only C3 plants, their δ13C values will be from −18.5 to −22.0‰ in their bone collagen and −14.5‰ in the hydroxylapatite of their teeth and bones. In contrast, C4 feeders will have bone collagen with a value of −7.5‰ and hydroxylapatite value of −0.5‰. In case studies, millet and maize eaters can easily be distinguished from rice and wheat eaters. Studying how these dietary preferences are distributed geographically through time can illuminate migration paths of people and dispersal paths of different agricultural crops. However, human groups have often mixed C3 and C4 plants (historically, northern Chinese subsisted on wheat (C3) and millet (C4)) or mixed plant and animal groups (for example, southeastern Chinese subsisting on rice and fish).
Sources: en.wikipedia.org
Legal status varies by country. It is not approved as a medicine, and it is prohibited in sport. Some jurisdictions restrict import, sale, or possession.
Laboratories use liquid chromatography-tandem mass spectrometry to detect GW501516 and its metabolites. Urine is commonly tested, and testing can occur in and out of competition.
No, cardarine is not a SARM. It is a PPARδ agonist, which acts on a different receptor. The two classes are often confused in online discussions.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.